Ampligen Study Take II: A Correction

March 18, 2012

Posted by Cort Johnson

The recent blog on Hemispherx’s Ampligen study has been amended to take account of the fact that the study involved an analysis of data from a 1998-2004 study. The blog in its original state suggested that this was a new study done in response to the FDA’s 2009 concerns. That was not true. Hemispherx may have done a re-analysis of old data in an attempt to comply with some of the FDA’s concerns but it did not, at least in this paper, embark on a new study with new patients. My apologies for any misconceptions.

Add Your Comment

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: